Effects of calcium and thrombin on growth factor release from platelet concentrates: Kinetics and regulation of endothelial cell proliferation

被引:108
作者
Martineau, I
Lacoste, E
Gagnon, G [1 ]
机构
[1] Univ Laval, Fac Med Dent, Ste Foy, PQ G1K 7P4, Canada
[2] Univ Laval, Grp Rech Ecol Buccale, Ste Foy, PQ G1K 7P4, Canada
关键词
platelet activation; thrombin; growth factors; endothelial cell; wound healing;
D O I
10.1016/j.biomaterials.2003.11.013
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Platelet concentrates (PCs) constitute new biological mediators used in osseous reconstructive surgery. In this study, we assessed (i) the effects of various concentrations of calcium and thrombin on the kinetics of platelet-derived growth factor (PDGF-BB), transforming growth factor-beta1 (TGF-beta1), basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) release by PCs and (ii) the contribution of PC supernatants to endothelial cell proliferation. Our results indicate that high concentrations of calcium (Ca) and thrombin (Thr) trigger an immediate and significant increase in bFGF, TGF-beta1 and PDGF-BB concentrations. Thereafter, PDGF-BB, VEGF and TGF-beta1 levels remained generally constant over a 6-day period while a decrease in bFGF concentrations was noted after 24 h. Lower Ca and Thr concentrations tended to reduce and delay growth factors release from PCs. Endothelial cell proliferation was greatly enhanced with PC supernatants (mean: 20-fold increase). This was especially evident when endothelial cells were treated with supernatants harvested early after PC treatment with high concentrations of Ca and Thr or later after PC treatment with low Ca and Thr concentrations. Additional research aiming to measure the effects of Ca and Thr on bone formation in vivo is needed. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4489 / 4502
页数:14
相关论文
共 59 条
[21]   ANGIOGENIC GROWTH-FACTORS - THEIR EFFECTS AND POTENTIAL IN SOFT-TISSUE WOUND-HEALING [J].
HOM, DB ;
MAISEL, RH .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1992, 101 (04) :349-354
[22]  
Ishikawa Osamu, 1992, Journal of Dermatology (Tokyo), V19, P657
[23]   Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease [J].
Isner, JM ;
Walsh, K ;
Symes, J ;
Pieczek, A ;
Takeshita, S ;
Lowry, J ;
Rosenfield, K ;
Weir, L ;
Brogi, E ;
Jurayj, D .
HUMAN GENE THERAPY, 1996, 7 (08) :959-988
[24]   Clinical evidence of angiogenesis after arterial gene transfer of phVEGF(165) in patient with ischaemic limb [J].
Isner, JM ;
Pieczek, A ;
Schainfeld, R ;
Blair, R ;
Haley, L ;
Asahara, T ;
Rosenfield, K ;
Razvi, S ;
Walsh, E ;
Symes, JF .
LANCET, 1996, 348 (9024) :370-374
[25]   Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: Case series [J].
Kassolis, JD ;
Rosen, PS ;
Reynolds, MA .
JOURNAL OF PERIODONTOLOGY, 2000, 71 (10) :1654-1661
[26]   Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction [J].
Kawamoto, A ;
Kawata, H ;
Akai, Y ;
Katsuyama, Y ;
Takase, E ;
Sasaki, Y ;
Tsujimura, S ;
Sakaguchi, Y ;
Iwano, M ;
Fujimoto, S ;
Hashimoto, T ;
Dohi, K .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 67 (01) :47-54
[27]  
KEIL B, 1992, SPECIFICITY PROTEOL
[28]   Clinical applications of bone graft substitutes [J].
Khan, SN ;
Tomin, E ;
Lane, JM .
ORTHOPEDIC CLINICS OF NORTH AMERICA, 2000, 31 (03) :389-+
[29]   Bone growth factors [J].
Khan, SN ;
Bostrom, MPG ;
Lane, JM .
ORTHOPEDIC CLINICS OF NORTH AMERICA, 2000, 31 (03) :375-+
[30]  
King Gaston N., 2001, Current Pharmaceutical Biotechnology, V2, P131, DOI 10.2174/1389201013378716